Norbert Frey, Norbert Frey, E. Olson (2003)
Cardiac hypertrophy: the good, the bad, and the ugly.Annual review of physiology, 65
T. McKinsey, Chun-li Zhang, E. Olson (2002)
MEF2: a calcium-dependent regulator of cell division, differentiation and death.Trends in biochemical sciences, 27 1
W. Maclellan, M. Schneider (2000)
Genetic dissection of cardiac growth control pathways.Annual review of physiology, 62
U. Kirchhefer, W. Schmitz, H. Scholz, J. Neumann (1999)
Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts.Cardiovascular research, 42 1
K. Chien (1999)
Stress Pathways and Heart FailureCell, 98
T. McKinsey, Chun Zhang, E. Olson (2000)
Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5.Proceedings of the National Academy of Sciences of the United States of America, 97 26
Jian-rong Lu, T. McKinsey, R. Nicol, E. Olson (2000)
Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.Proceedings of the National Academy of Sciences of the United States of America, 97 8
E. Olson, M. Schneider (2003)
Sizing up the heart: development redux in disease.Genes & development, 17 16
Y. Hamamori, M. Schneider (2003)
HATs off to Hop: recruitment of a class I histone deacetylase incriminates a novel transcriptional pathway that opposes cardiac hypertrophy.The Journal of clinical investigation, 112 6
Rosalind Gusterson, E. Jazrawi, I. Adcock, D. Latchman (2003)
The Transcriptional Co-activators CREB-binding Protein (CBP) and p300 Play a Critical Role in Cardiac Hypertrophy That Is Dependent on Their Histone Acetyltransferase Activity*The Journal of Biological Chemistry, 278
Chun Zhang, T. McKinsey, Jian-rong Lu, E. Olson (2001)
Association of COOH-terminal-binding Protein (CtBP) and MEF2-interacting Transcription Repressor (MITR) Contributes to Transcriptional Repression of the MEF2 Transcription Factor*The Journal of Biological Chemistry, 276
Tong Zhang, Eric Johnson, Yusu Gu, M. Morissette, V. Sah, Marisa Gigena, D. Belke, W. Dillmann, T. Rogers, H. Schulman, J. Ross, J. Brown (2002)
The Cardiac-specific Nuclear δB Isoform of Ca2+/Calmodulin-dependent Protein Kinase II Induces Hypertrophy and Dilated Cardiomyopathy Associated with Increased Protein Phosphatase 2A Activity*The Journal of Biological Chemistry, 277
Xianbo Zhou, P. Marks, R. Rifkind, V. Richon (2001)
Cloning and characterization of a histone deacetylase, HDAC9Proceedings of the National Academy of Sciences of the United States of America, 98
D. Sparrow, E. Miska, E. Langley, Sorogini Reynaud-Deonauth, S. Kotecha, N. Towers, G. Spohr, T. Kouzarides, T. Mohun (1999)
MEF‐2 function is modified by a novel co‐repressor, MITRThe EMBO Journal, 18
T. Jenuwein, C. Allis (2001)
Translating the Histone CodeScience, 293
Manyari De (1990)
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.The New England journal of medicine, 323 24
H. Youn, T. Chatila, Jun Liu (2000)
Integration of calcineurin and MEF2 signals by the coactivator p300 during T‐cell apoptosisThe EMBO Journal, 19
Takahiro Kato, M. Sano, S. Miyoshi, Toshihiko Sato, D. Hakuno, H. Ishida, Hiroe Kinoshita-Nakazawa, K. Fukuda, S. Ogawa (2000)
Calmodulin Kinases II and IV and Calcineurin Are Involved in Leukemia Inhibitory Factor–Induced Cardiac Hypertrophy in RatsCirculation Research: Journal of the American Heart Association, 87
R. Fentzke, C. Korcarz, R. Lang, Hua-Heng Lin, J. Leiden (1998)
Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart.The Journal of clinical investigation, 101 11
Chun-li Zhang, T. McKinsey, E. Olson (2002)
Association of Class II Histone Deacetylases with Heterochromatin Protein 1: Potential Role for Histone Methylation in Control of Muscle DifferentiationMolecular and Cellular Biology, 22
E. Miska, C. Karlsson, E. Langley, S. Nielsen, J. Pines, T. Kouzarides (1999)
HDAC4 deacetylase associates with and represses the MEF2 transcription factorThe EMBO Journal, 18
P. Marks, R. Rifkind, V. Richon, R. Breslow, Thomas Miller, W. Kelly (2001)
Histone deacetylases and cancer: causes and therapiesNature Reviews Cancer, 1
T. McKinsey, Chun-li Zhang, Jian-rong Lu, E. Olson (2000)
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiationNature, 408
C. Grozinger, S. Schreiber (2000)
Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization.Proceedings of the National Academy of Sciences of the United States of America, 97 14
J. Hill, M. Karimi, W. Kutschke, R. Davisson, Kathy Zimmerman, Zhengyi Wang, R. Kerber, Robert Weiss (2000)
Cardiac hypertrophy is not a required compensatory response to short-term pressure overload.Circulation, 101 24
B. Rothermel, T. McKinsey, Rick Vega, R. Nicol, P. Mammen, John Yang, C. Antos, J. Shelton, R. Bassel-Duby, E. Olson, R. Williams (2001)
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivoProceedings of the National Academy of Sciences of the United States of America, 98
Jian-rong Lu, T. McKinsey, Chun-li Zhang, E. Olson (2000)
Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases.Molecular cell, 6 2
J. Mathew, P. Sleight, E. Lonn, David Johnstone, J. Pogue, Q. Yi, J. Bosch, B. Sussex, J. Probstfield, S. Yusuf (2001)
Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor RamiprilCirculation: Journal of the American Heart Association, 104
V. Sartorelli, Jing Huang, Y. Hamamori, L. Kedes (1997)
Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2CMolecular and Cellular Biology, 17
Xiaoyang Wu, Hui Li, Eun-Ju Park, J. Chen (2001)
SMRTe Inhibits MEF2C Transcriptional Activation by Targeting HDAC4 and 5 to Nuclear Domains*The Journal of Biological Chemistry, 276
U. Mahlknecht, S. Schnittger, O. Ottmann, C. Schoch, M. Mosebach, W. Hiddemann, D. Hoelzer (2000)
Chromosomal organization and localization of the human histone deacetylase 5 gene (HDAC5).Biochimica et biophysica acta, 1493 3
H. Kook, J. Lepore, A. Gitler, M. Lu, Wendy Yung, J. Mackay, R. Zhou, V. Ferrari, P. Gruber, J. Epstein (2003)
Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop.The Journal of clinical investigation, 112 6
Chun-li Zhang, T. McKinsey, E. Olson (2001)
The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesisProceedings of the National Academy of Sciences of the United States of America, 98
T. Yanazume, T. Morimoto, H. Wada, Teruhisa Kawamura, K. Hasegawa (2003)
Biological role of p300 in cardiac myocytesMolecular and Cellular Biochemistry, 248
L. Windt, Hae Lim, O. Bueno, Qiangrong Liang, U. Delling, Julian Braz, B. Glascock, Thomas Kimball, F. Monte, R. Hajjar, J. Molkentin (2001)
Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivoProceedings of the National Academy of Sciences of the United States of America, 98
H. Rockman, W. Koch, R. Lefkowitz (2002)
Seven-transmembrane-spanning receptors and heart functionNature, 415
Chun-li Zhang, T. McKinsey, Shurong Chang, C. Antos, Joseph Hill, E. Olson (2002)
Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac HypertrophyCell, 110
T. McKinsey, E. Olson (2004)
Cardiac histone acetylation--therapeutic opportunities abound.Trends in genetics : TIG, 20 4
N. Frey, H. Katus, E. Olson, Joseph Hill (2004)
Hypertrophy of the heart: a new therapeutic target?Circulation, 109 13
S. Roth, J. Denu, C. Allis (2001)
Histone acetyltransferases.Annual review of biochemistry, 70
M. Koren, R. Devereux, P. Casale, D. Savage, J. Laragh (1991)
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.Annals of internal medicine, 114 5
C. Antos, T. McKinsey, M. Dreitz, L. Hollingsworth, Chun-li Zhang, K. Schreiber, H. Rindt, R. Gorczynski, E. Olson (2003)
Dose-dependent Blockade to Cardiomyocyte Hypertrophy by Histone Deacetylase Inhibitors*Journal of Biological Chemistry, 278
E. Verdin, F. Dequiedt, H. Kasler (2003)
Class II histone deacetylases: versatile regulators.Trends in genetics : TIG, 19 5
R. Passier, H. Zeng, Norbert Frey, F. Naya, R. Nicol, T. McKinsey, P. Overbeek, J. Richardson, S. Grant, E. Olson (2000)
CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.The Journal of clinical investigation, 105 10
F. Naya, Chuanzhen Wu, James Richardson, P. Overbeek, Eric Olson (1999)
Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene.Development, 126 10
B. Lowes, E. Gilbert, W. Abraham, W. Minobe, P. Larrabee, D. Ferguson, E. Wolfel, J. Lindenfeld, T. Tsvetkova, A. Robertson, R. Quaife, M. Bristow (2002)
Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.The New England journal of medicine, 346 18
Steves Morin, F. Charron, L. Robitaille, M. Nemer (2000)
GATA‐dependent recruitment of MEF2 proteins to target promotersThe EMBO Journal, 19
W. Fischle, F. Dequiedt, M. Hendzel, M. Guenther, M. Lazar, W. Voelter, E. Verdin (2002)
Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR.Molecular cell, 9 1
J. Molkentin, Jian-rong Lu, C. Antos, B. Markham, J. Richardson, J. Robbins, S. Grant, E. Olson (1998)
A Calcineurin-Dependent Transcriptional Pathway for Cardiac HypertrophyCell, 93
Molecular and Cellular Biology – Unpaywall
Published: Sep 14, 2004
Access the full text.
Sign up today, get DeepDyve free for 14 days.